Published in Anti-Infectives Week, September 8th, 2003
The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening.
In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversa's small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
Source: Anti-Infectives Week (2003-09-08)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.